30Plus Study

The effect of 30Plus on Premenstrual Syndrome: a randomised controlled study

Status

Not yet recruiting

Phases

Phase 1

Study type

Interventional

Source

ANZCTR

Registry ID

ACTRN12606000021572

Enrollment

110

Registered

2006-01-13

Start date

2006-02-01

Completion date

Unknown

Last updated

2020-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

The intervention group would be women randomised into a group that will receive the 30Plus and

Study design

Allocation

Randomised controlled trial

Intervention model

Parallel

Primary purpose

Treatment

Masking

Blinded (masking used)

Eligibility

Sex/Gender

All

Age

18 Years to 45 Years

Healthy volunteers

Inclusion criteria

Have at least one of these psychological and physical symptoms during the 5 days before menses: Psychology: Depression, angry outbursts, irritability, anxiety, confusion or social withdrawal.Physical: Breast tenderness, abdominal bloating, headache, swelling of extremities.

Exclusion criteria

Usage of hormonal therapies such as hormone replacement therapy (HRT) or the oral contraceptive pill (OCP), Usage of herbals and vitamins known to have an effect on PMS, Severe depression.

Outcome results